Thalys Medical Technology Group Management

Management criteria checks 0/4

We currently do not have sufficient information about the CEO.

Key information

Zheng Wang

Chief executive officer

CN¥1.0m

Total compensation

CEO salary percentage	n/a
CEO tenure	no data
CEO ownership	0.0009%
Management average tenure	1.9yrs
Board average tenure	less than a year

Recent management updates

Recent updates

Thalys Medical Technology Group Corporation (SHSE:603716) Shares Fly 26% But Investors Aren't Buying For Growth

Nov 20

Thalys Medical Technology Group Corporation (SHSE:603716) Surges 28% Yet Its Low P/S Is No Reason For Excitement

Aug 12

CEO

Zheng Wang (57 yo)

no data

Tenure

CN¥1,005,300

Compensation

Mr. Zheng Wang serves as Director at Thalys Medical Technology Group Inc. and serves as its General Manager. He served as Deputy General Manager at Thalys Medical Technology Group Inc. (formerly known as T...

Leadership Team

Name	Position	Tenure	Compensation	Ownership
Zheng Wang	GM & Director	no data	CN¥1.01m	0.00086% CN¥ 13.2k
Yan Shen	Chief Financial Officer	1.8yrs	CN¥400.90k	no data
Li Fan	Deputy GM	no data	CN¥600.00k	0.0080% CN¥ 123.1k
Xiao Ming Wen	Director of GM Office & Director	no data	CN¥644.00k	no data
Feng Cai	Board Secretary	2.2yrs	CN¥600.00k	0.0053% CN¥ 82.1k
Yi Lu	Deputy General Manager	1.9yrs	CN¥698.00k	0.012% CN¥ 184.7k
Jun Sun	Administrative Director	no data	no data	no data
Feng Liu	GM of SPD Business & Regional Inspection Center Business Department and Deputy GM	no data	CN¥704.00k	no data

1.9yrs

Average Tenure

49yo

Average Age

Experienced Management: 603716's management team is not considered experienced ( 1.9 years average tenure), which suggests a new team.

Board Members

Name	Position	Tenure	Compensation	Ownership
Zheng Wang	GM & Director	no data	CN¥1.01m	0.00086% CN¥ 13.2k
Li Fan	Deputy GM	no data	CN¥600.00k	0.0080% CN¥ 123.1k
Xiao Ming Wen	Director of GM Office & Director	no data	CN¥644.00k	no data
Zhaoguo Zhang	Independent Director	less than a year	no data	no data
Wei Wen	Chairman	no data	CN¥900.00k	5.15% CN¥ 79.1m
Yicheng Wen	Director	no data	CN¥425.30k	no data
De Chen	Assistant to the GM & Chairman of the Supervisory Board	no data	no data	no data
Jing Tu	Supervisor	no data	no data	no data
Fei Xiong	Director of Bidding	no data	no data	no data
Zhen Zhang	Independent Director	less than a year	no data	no data
Xianwang Shi	Independent Director	less than a year	no data	no data

0.3yrs

Average Tenure

50yo

Average Age

Experienced Board: 603716's board of directors are not considered experienced ( 0.3 years average tenure), which suggests a new board.

Thalys Medical Technology Group Management

Management criteria checks 0/4

Key information

Recent management updates

Thalys Medical Technology Group Corporation, Annual General Meeting, May 20, 2024

Thalys Medical Technology Group Corporation, Annual General Meeting, May 20, 2024

Less than half of directors are independent

Less than half of directors are independent

Recent updates

Thalys Medical Technology Group Corporation (SHSE:603716) Shares Fly 26% But Investors Aren't Buying For Growth

Third quarter 2024 earnings released: CN¥0.42 loss per share (vs CN¥0.033 loss in 3Q 2023)

Wuhan Herun Ruihui Business Consulting Co., Ltd. agreed to acquire 80% stake in Wuhan Huixin Technology Development Co., Ltd. from Thalys Medical Technology Group Corporation (SHSE:603716) for CNY 72 million.

Thalys Medical Technology Group Corporation to Report Q3, 2024 Results on Oct 29, 2024

Thalys Medical Technology Group Corporation (SHSE:603716) Surges 28% Yet Its Low P/S Is No Reason For Excitement

Thalys Medical Technology Group Corporation to Report First Half, 2024 Results on Aug 30, 2024

Thalys Medical Technology Group Corporation (SHSE:603716) announces an Equity Buyback for CNY 20 million worth of its shares.

Thalys Medical Technology Group Corporation, Annual General Meeting, May 20, 2024

First quarter 2024 earnings released: EPS: CN¥0.02 (vs CN¥0.07 loss in 1Q 2023)

Thalys Medical Technology Group Corporation, Annual General Meeting, May 20, 2024

Thalys Medical Technology Group Corporation to Report Q1, 2024 Results on Apr 27, 2024

An undisclosed buyer acquired 51% stake in Shanxi Thalys Medical Technology Co., Ltd. from Thalys Medical Technology Group Corporation (SHSE:603716) for CNY 1.53 million.

Thalys Medical Technology Group Corporation (SHSE:603716) announces an Equity Buyback for CNY 20 million worth of its shares.

Thalys Medical Technology Group Corporation to Report Fiscal Year 2023 Results on Apr 27, 2024

New major risk - Financial position

Second quarter 2023 earnings released: EPS: CN¥0.084 (vs CN¥0.099 loss in 2Q 2022)

New minor risk - Share price stability

Thalys Medical Technology Group Corporation to Report First Half, 2023 Results on Aug 30, 2023

First quarter 2023 earnings released: CN¥0.07 loss per share (vs CN¥0.10 profit in 1Q 2022)

Less than half of directors are independent

Third quarter 2022 earnings released: CN¥0.016 loss per share (vs CN¥0.012 loss in 3Q 2021)

Second quarter 2022 earnings released: CN¥0.099 loss per share (vs CN¥0.012 loss in 2Q 2021)

Huang Jianfeng completed the acquisition of Thalys Medical Technology Group Inc. (SHSE:603716) from Saihai (Shanghai) Health Technology Co., Ltd.

Full year 2021 earnings: EPS and revenues exceed analyst expectations

Less than half of directors are independent

Second quarter 2021 earnings released: CN¥0.012 loss per share (vs CN¥0.18 profit in 2Q 2020)

Investor sentiment improved over the past week

First quarter 2021 earnings released: EPS CN¥0.03 (vs CN¥0.12 loss in 1Q 2020)

New 90-day low: CN¥14.45

New 90-day low: CN¥14.50

New 90-day high: CN¥17.71

New 90-day low: CN¥14.70

Third quarter earnings released

Thalys Medical Technology Group Inc. to Report Q3, 2020 Results on Oct 30, 2020

New 90-day high - CN¥18.10

First half earnings released

Thalys Medical Technology Inc. (SHSE:603716) agreed to acquire remaining 49% stake in Shanghai Thalys Medical Technology Co., Ltd. from Liu Hongkui and Zhang Luqi for CNY 0.

New 90-day high - CN¥17.33

CEO

Tenure

Compensation

Leadership Team

Average Tenure

Average Age

Board Members

Average Tenure

Average Age